Aandelen in “Nierdialyse Centra”

Aandeel	Datum	Koers	Evolutie
DaVita Inc	6/02	140,830 USD -5,62%	-5,62%

Nieuws over “Nierdialyse Centra”

Toon enkel gratis nieuws

2/02 · DaVita Inc. 4th Quarter 2025 Results · Persbericht

2/02 · DaVita Inc. 4th Quarter 2025 Results · Persbericht

21/01 · DaVita Inc. Schedules 4th Quarter 2025 Investor Conference Call · Persbericht

9/01 · Fresenius Medical Care accelerates the second tranche of its EUR 1 billion share buyback program with around EUR 415 million repurchase planned · Persbericht

11/12 · DaVita Names New Leaders to Accelerate Care Transformation · Persbericht

10/12 · Fresenius Medical Care appoints Charles Hugh-Jones as Global Chief Medical Officer and member of the Management Board · Persbericht

14/11 · DaVita Inc. to Participate in Fireside Chat with Wolfe Research · Persbericht

Mijn selecties

Je selectie is nog leeg.

Voeg nu effecten toe